TCG Crossover Management »

Biohaven shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $52M 4.6M 11.29

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cogent Biosciences Comm (COGT)
Cg Oncology Comm (CGON)
Tango Therapeutics Comm (TNGX)
Centessa Pharmaceuticals Adrs (CNTA)
Dyne Therapeutics Comm (DYN)
Rapt Therapeutics Comm (RAPT)
Tyra Biosciences Comm (TYRA)
Amylyx Pharmaceuticals Comm (AMLX)
Savara Comm (SVRA)
Monte Rosa Therapeutics Comm (GLUE)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Eyepoint Pharmaceuticals Comm (EYPT)
Structure Therapeutics Adrs (GPCR)

View all positions for TCG Crossover Management

Top funds holding Biohaven

Suvretta Capital Management
Stifel Financial
BlackRock
Henderson Group
State Street Corporation
TCG Crossover Management
Vanguard Group
FMR
Geode Capital Management
Susquehanna International
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Caption Management
Infinitum Asset Management
Schonfeld Strategic Advisors

View all funds holding Biohaven